Literature DB >> 8622503

Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group.

P Lange1, C S Ulrik, J Vestbo.   

Abstract

BACKGROUND: On the question of whether asthma shortens survival the published work gives no clear answer. We have prospectively analysed overall and cause-specific mortality in persons with self-reported asthma. METHODS A sample of 13 540 individuals (6104 men) 20 years of age or older, randomly selected from the general population of the city of Copenhagen, was followed for 17 years.
FINDINGS: Survival in participants with self-reported asthma was significantly poorer than in non-asthmatics, the excess mortality being limited to pulmonary mortality. After statistical adjustment for age, length of school education, and smoking, women with asthma had a 1.7 higher risk of dying than women without asthma (95% confidence interval 1.3--2.2). Although the relative risk (RR) of dying with asthma was slightly lower in men (RR = 1.5, 95% Cl 1.2-1.9) the difference between sexes was not significant. The results were similar within smoking groups and the highest risk of death associated with asthma was seen among never-smokers (RR = 2.1, 95% Cl 1.6-2.3). Inclusion of one-second forced expiratory volume, in % predicted, in the mortality analyses showed that the increased risk of death associated with asthma was mediated mainly through reduced lung function.
INTERPRETATION: We conclude that, in the general population, self-reported asthma is associated with a slight excess of mortality, mainly from respiratory diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8622503     DOI: 10.1016/s0140-6736(96)90937-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

Review 1.  Onset and outcome of asthma in older adults. A clinician's perspective.

Authors:  Charles E Reed
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

2.  Mortality of elderly subjects with self-reported asthma in a French cohort, 1991-1996.

Authors:  C Dantzer; J F Tessier; C Nejjari; P Barberger-Gateau; J F Dartigues
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 3.  Status asthmaticus. From the emergency department to the intensive care unit.

Authors:  N Kenyon; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 4.  Airway hyperresponsiveness and COPD mortality.

Authors:  J Vestbo; E F Hansen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 5.  Low dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  J C Kips; R A Pauwels
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 6.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

Authors:  H M Lamb; C R Culy; D Faulds
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

7.  Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.

Authors:  H F Guite; R Dundas; P G Burney
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 8.  Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 9.  Update on the "Dutch hypothesis" for chronic respiratory disease.

Authors:  J Vestbo; E Prescott
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 10.  Epidemiology of the origins of airflow limitation in asthma.

Authors:  Stefano Guerra; Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.